In this week's episode of GameChangers Podcast, we delve into the groundbreaking reclassification of marijuana to Schedule III. We discuss impacts on the legal landscape, medical research, pharmacogenomics for CBD, and the role of healthcare providers.

The GameChanger
Marijuana's move to Schedule III will increase research opportunities, ease fear and stigma, and provide healthcare provider involvement in medical benefits and potential risks.

Host
Jen Moulton, BSPharm
President, CEimpact

Guests
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Marry Vuong, PharmD, BCPPS
Clinical Pharmacy Manager
Perfecting Peds

Reference
UPDATE: DEA Moves to Reschedule Cannabis from Cannabis Business Times

NPR: Scientists welcome new rules on marijuana, but research will still face obstacles.


Pharmacists, REDEEM YOUR CPE HERE!
CPE is available to Health Mart franchise members only
To learn more about Health Mart, click here: https://join.healthmart.com/

CPE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the reclassification of marijuana from Schedule I to Schedule III.
2. Explain the potential benefits of the marijuana schedule change including its impact on medical research and patient access.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-180-H01-P
Initial release date: 05/27/2024
Expiration date: 05/27/2025
Additional CPE details can be found here.